Symbol Insights

You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.

Insights for Glenmark Pharmaceuticals Ltd
National Stock Exchange: GLENMARK
11 - Losing Steam - loss-making but can fund turnaround
Sector: Misc
Industry: Misc
Today's Price
updated on: 		1540.0 (2.68%)
Open 1485.1 (3.7%)
High (Upside %) 1553.4 (0.87%)
Low (Downside %) 1485.1 (3.7%)
P. Close 1499.85 (2.68%)
Open-High % 4.6%
Open-Low % 0.0%
Low-High % 4.6%
Previous Data

GLENMARK is a Stock listed in the India on the National Stock Exchange under the ticker 'GLENMARK'

Company Profile

Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in India, North America, Latin America, Europe, Japan, and internationally. The company provides branded and generic formulations in the therapeutic areas of dermatology, respiratory, and oncology; and various active pharmaceutical ingredients. Its product pipeline includes ISB 2001, a BCMA x CD38 x CD3 trispecific antibody, which is in Phase 1 clinical trial for oncology; GRC 39815, a retinoid-related orphan receptor gamma t inverse agonist, which is in Phase 1 clinical trial for the treatment of chronic obstructive pulmonary disease; and GRC 54276, a hematopoietic progenitor kinase 1 inhibitor, which is in Phase 1 clinical trial for the treatment of solid tumors. Its pipeline also comprises ISB 1342, CD38 X CD3 bispecific antibody, which is in Phase 1 clinical trial for the treatment of relapsed/refractory multiple myeloma; ISB 1442, a CD38 x CD47 immune cell engager, which is in Phase 1 clinical trial for the treatment of relapsed/refractory multiple myeloma; ISB 880, a IL-1RAP antibody, which is in Phase 1 clinical trial for the treatment of autoimmune diseases; and ISB 830, a OX40 antagonist, which is in Phase 2 clinical trial for the treatment of atopic dermatitis. In addition, the company offers Ryaltris nasal spray for the treatment of seasonal allergic rhinitis. Glenmark Pharmaceuticals Limited was incorporated in 1977 and is based in Mumbai, India.

source:https://finance.yahoo.com/GLENMARK.NS/profile

Basic Stats
Market Cap-Display Market Cap-Actual Market Cap Enterprise Value-Display Enterprise Value-Actual Enterprise Value Forward P/E Price/Sales Price/Book Enterprise Value/Revenue Enterprise Value/EBITDA Profit Margin Operating Margin Revenue-Display Revenue-Actual Revenue Quarterly Revenue Growth EBITDA-Display EBITDA-Actual EBITDA Diluted EPS Quarterly Earnings Growth Total Cash-Display Total Cash-Actual Total Cash Total Debt-Display Total Debt-Actual Total Debt Total Debt/Equity Operating Cash Flow-Display Levered Free Cash Flow-Display % Held by Insiders % Held by Institutions
39502.0 Cr 395020000000.0 39502.0 39242.0 Cr 392420000000.0 39242.0 14.9 3.26 4.68 3.24 20.93 -10.20% 14.50% 12861.0 Cr 128610000000.0 12861.0 -4.60% 2344.0 Cr 23440000000.0 2344.0 -36.1 126.90% 1659.0 Cr 16590000000.0 1659.0 1231.0 Cr 12310000000.0 1231.0 0.15689999999999998 nan Cr nan Cr 50.60% 24.46%

source:https://finance.yahoo.com/GLENMARK.NS/key-statistics

Reading Information

source:https://finance.yahoo.com/GLENMARK.NS/key-statistics

source:https://www.google.com/finance/quote/GLENMARK:NSE

source:https://finance.yahoo.com/GLENMARK.NS/analysis

source:https://finance.yahoo.com/GLENMARK.NS/fair-value

Upside-Downside Spread
Key Weighted 5D 1M 3M 6M 1Y 3Y 10Y
Upside % (high) 6.96% -1.56% (1516) 6.2% (1635.45) 15.37% (1776.75) 18.89% (1830.95) 18.89% (1830.95) 18.89% (1830.95) 18.89% (1830.95)
Downside % (low) 13.55% 9.48% (1394) 11.16% (1368.15) 11.16% (1368.15) 11.16% (1368.15) 49.94% (771) 77.37% (348.5) 89.5% (161.65)
Spread % -6.6% -11.04% -4.96% 4.21% 7.73% -31.04% -58.48% -70.61%

GLENMARK's price used for computing the stats is 1540.0 as on date

Cumulative Return Percent
Key Today 5D 1M 3M 6M 1Y 3Y 10Y
Last Price-Trend PrevClose 2.68% 5.97% -5.4% -9.37% 4.85% 74.09% 218.87% 87.04%
Last Price 1540.0 1540.0 1540.0 1540.0 1540.0 1540.0 1540.0 1540.0
Trend-Previous Close 1499.85 1453.2 1627.9 1699.25 1468.75 884.6 482.95 823.35

GLENMARK's symbol cumulative return percent is computed basis data from date

Return Velocity
5D 2W 1M 3M 6M 1Y
5D window
Metric Mean Median Stdev
Overall 1.97% 2.61% 1.45%
Up 2.79% 3.21% 1.6%
Down -1.56% -2.37% 1.39%
5D Opportunity: SELL-ACTIVE
returns: 5.97% (4.39%), p.close: 1453.2
entry: 1517.04, exit: 1512.09, return: 0.33%
Metric Mean Median Stdev
Overall -1.08% 0.04% 3.87%
Up 1.61% 0.7% 1.65%
Down -3.91% -3.1% 2.84%
5D Opportunity: SELL-ACTIVE
returns: 5.97% (3.26%), p.close: 1453.2
entry: 1500.62, exit: 1509.99, return: -0.62%
Metric Mean Median Stdev
Overall -2.46% -2.02% 4.19%
Up 1.23% 0.56% 1.44%
Down -4.33% -3.55% 3.05%
5D Opportunity: SELL-ACTIVE
returns: 5.97% (2.67%), p.close: 1453.2
entry: 1491.97, exit: 1484.79, return: 0.48%
Metric Mean Median Stdev
Overall -0.99% -0.04% 4.42%
Up 1.88% 1.75% 1.71%
Down -2.94% -1.9% 3.28%
5D Opportunity: SELL-ACTIVE
returns: 5.97% (3.59%), p.close: 1453.2
entry: 1505.35, exit: 1516.78, return: -0.76%
Metric Mean Median Stdev
Overall 0.15% 0.35% 4.53%
Up 2.44% 2.01% 2.61%
Down -2.25% -1.33% 2.75%
5D Opportunity: SELL-ACTIVE
returns: 5.97% (5.05%), p.close: 1453.2
entry: 1526.62, exit: 1524.11, return: 0.16%
Metric Mean Median Stdev
Overall 1.08% 1.2% 4.48%
Up 2.85% 2.25% 2.97%
Down -1.89% -1.08% 2.44%
5D Opportunity: SELL-ACTIVE
returns: 5.97% (5.82%), p.close: 1453.2
entry: 1537.76, exit: 1535.65, return: 0.14%
2W window
Metric Mean Median Stdev
Overall -2.88% -2.46% 3.3%
Up 1.52% 1.02% 1.36%
Down -5.97% -6.57% 1.43%
2W Opportunity: SELL-ACTIVE
returns: 6.2% (2.88%), p.close: 1450.1
entry: 1491.88, exit: 1462.36, return: 1.98%
Metric Mean Median Stdev
Overall -4.75% -5.73% 3.9%
Up 1.54% 0.95% 1.72%
Down -6.85% -6.87% 2.8%
2W Opportunity: SELL-ACTIVE
returns: 6.2% (3.26%), p.close: 1450.1
entry: 1497.36, exit: 1423.62, return: 4.92%
Metric Mean Median Stdev
Overall -2.13% -1.02% 5.81%
Up 2.75% 2.48% 2.34%
Down -4.78% -3.89% 4.38%
2W Opportunity: SELL-ACTIVE
returns: 6.2% (5.09%), p.close: 1450.1
entry: 1523.84, exit: 1519.49, return: 0.29%
Metric Mean Median Stdev
Overall 0.28% 0.53% 6.48%
Up 3.96% 3.09% 3.97%
Down -3.47% -2.0% 3.74%
2W Opportunity: SELL-APPROACHING
returns: 6.2% (7.93%), p.close: 1450.1
entry: 1565.09, exit: 1551.68, return: 0.86%
Metric Mean Median Stdev
Overall 2.16% 1.86% 6.52%
Up 4.86% 3.76% 4.39%
Down -2.88% -1.71% 3.38%
2W Opportunity: SELL-APPROACHING
returns: 6.2% (9.25%), p.close: 1450.1
entry: 1584.19, exit: 1571.62, return: 0.79%
1M window
Metric Mean Median Stdev
Overall -5.78% -5.68% 4.82%
Up 4.74% 6.17% 3.08%
Down -7.96% -5.77% 5.13%
1M Opportunity:
returns: -5.4% (13.09%), p.close: 1627.9
entry: 1414.81, exit: 1456.9, return: 2.98%
Metric Mean Median Stdev
Overall -4.74% -6.66% 6.98%
Up 4.16% 4.64% 2.74%
Down -7.99% -7.2% 5.69%
1M Opportunity:
returns: -5.4% (13.69%), p.close: 1627.9
entry: 1405.07, exit: 1405.85, return: 0.06%
Metric Mean Median Stdev
Overall 1.56% 1.07% 9.78%
Up 7.54% 5.93% 5.9%
Down -4.9% -2.93% 5.25%
1M Opportunity: BUY-APPROACHING
returns: -5.4% (10.15%), p.close: 1627.9
entry: 1462.65, exit: 1486.18, return: 1.61%
Metric Mean Median Stdev
Overall 4.99% 4.87% 9.49%
Up 9.07% 7.44% 6.16%
Down -4.2% -2.67% 4.53%
1M Opportunity: BUY-APPROACHING
returns: -5.4% (8.73%), p.close: 1627.9
entry: 1485.75, exit: 1552.64, return: 4.5%

GLENMARK's symbol current price is 1540.0 (2.68%) as on . Yesterday's close was 1499.85. It's return velocities are computed basis data from date .

Win Percent
Key Weighted 5D 1M 3M 6M 1Y 3Y
Open-High (> 1.0%) 57.95% 60.0% 59.09% 53.03% 55.3% 56.75% 57.41%
Open-Low (> 1.0%) 49.36% 40.0% 54.55% 57.58% 54.55% 54.76% 55.69%
Open-Close-Up (> 0.5%) 36.51% 40.0% 31.82% 36.36% 34.85% 39.29% 38.36%
Open-Close-Down (> 0.5%) 41.17% 40.0% 45.45% 39.39% 37.12% 34.52% 38.1%
Low-Close-Up (> 1.0%) 65.0% 80.0% 54.55% 54.55% 54.55% 62.7% 55.82%
High-Close-Down (> 1.0%) 60.33% 60.0% 63.64% 57.58% 58.33% 56.35% 55.95%

GLENMARK's symbol win percent is computed basis data from date

Associated Tags